News|Videos|October 23, 2024

How Climate Change Impact Is Changing Infectious Disease Patterns

Peter Rabinowitz, MD, MPH, discusses how climate change, including extreme weather and temperature shifts, is reshaping the spread of infectious diseases like dengue, leptospirosis, and Valley fever.

This article first appeared in our sister brand, Managed Healthcare Executive.

Warmer weather and the sharp ups and downs of wetter conditions from floods and hurricanes and drier conditions from drought are changing where and when certain infectious diseases occur — and clinicians need to be on the lookout for them, says Peter Rabinowitz, MD, MPH, a professor of environmental and occupational health sciences and director of the University of Washington School of Public Health Center for One Health Research in Seattle. Rabinowitz was a speaker at 2 sessions on climate change year at the 2024 ID Week meeting in Los Angeles, California, held from October 16 -20, 2024.

Rabinowitz, who trained as a family physician, said it is essential for clinicians to know how climate change alters infectious diseases. As the climate becomes more volatile, diseases not typically seen in certain areas may start to occur and become common.

For example, warmer weather will mean an increase in some areas of mosquito-borne diseases, such as dengue fever, Zika, and chikungunya, Rabinowitz said in an interview with Infection Control Today’s sister brand, Managed Healthcare Executive (MHE).

Rabinowitz told MHE that wet conditions after flooding from hurricanes and other extreme weather events are likely to make leptospirosis more common. Leptospira bacteria cause leptospirosis in animals' urine, and flood waters can become contaminated with the urine of infected animals.

Droughts are another climate change-driven factor altering the who, where, and when of infectious diseases. They can change the range of ticks and, therefore, the risk of tick-borne disease, said Rabinowitz, who is also codirector of UW Alliance for Pandemic Preparedness.

He noted that extensive periods of dry weather can also mean the emergence of dust-borne diseases, such as Valley fever. Valley fever, also called coccidioidomycosis, is a lung infection caused by inhaling the spores from the Coccidioides fungus that lives in the soil in dry areas of the US.


Related to this article

Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
Can a UV-C robot make up for a surface that wasn't properly cleaned? Experts say that's the wrong way to think about the technology. UV-C can provide an additional layer of microbial reduction, but factors including shadows, distance, positioning, and exposure time mean it cannot replace thorough manual cleaning and disinfection.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.
Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)
“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.